Kristin Brooks02.25.14
Jane Winter has been appointed senior vice president of INC Research’s Global Consulting unit. Ms. Winter will lead the unit, which provides consulting services in the areas of drug development and commercialization, regulatory consulting and submissions, and quality assurance (QA). She will be based in the UK.
Ms. Winter has more than 30 years of experience in the pharmaceutical industry. Prior to joining the company, she served as interim global head of outsourcing at a major Japanese biopharmaceutical company, where she was responsible for leading the rollout of its global vendor governance and oversight model. Ms. Winter has also held senior management positions with international pharma companies and CROs, including project and operations management, clinical development, strategic business planning and international clinical affairs. She established her own consulting company, Pharma Business Solutions Ltd., to assist biopharma companies and CROs maximize the effectiveness of clinical development and outsourcing.
Alistair Macdonald, INC’s chief operating officer, said, “To expand the breadth of support to our customers, INC Research has continued to strengthen our consulting practice with a number of senior appointments, including Jane’s. Her leadership and broad pharmaceutical background will be instrumental as we look to expand our integrated services model to include clinical development optimization and compliance. These additions, combined with our strategy, QA and regulatory practice areas, provide the complete framework to address our customers’ most pressing business needs in drug development today.”
Ms. Winter has more than 30 years of experience in the pharmaceutical industry. Prior to joining the company, she served as interim global head of outsourcing at a major Japanese biopharmaceutical company, where she was responsible for leading the rollout of its global vendor governance and oversight model. Ms. Winter has also held senior management positions with international pharma companies and CROs, including project and operations management, clinical development, strategic business planning and international clinical affairs. She established her own consulting company, Pharma Business Solutions Ltd., to assist biopharma companies and CROs maximize the effectiveness of clinical development and outsourcing.
Alistair Macdonald, INC’s chief operating officer, said, “To expand the breadth of support to our customers, INC Research has continued to strengthen our consulting practice with a number of senior appointments, including Jane’s. Her leadership and broad pharmaceutical background will be instrumental as we look to expand our integrated services model to include clinical development optimization and compliance. These additions, combined with our strategy, QA and regulatory practice areas, provide the complete framework to address our customers’ most pressing business needs in drug development today.”
